These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 11015127)
1. Early changes in respiratory compliance and resistance during the development of bronchopulmonary dysplasia in the era of surfactant therapy. Lui K; Lloyd J; Ang E; Rynn M; Gupta JM Pediatr Pulmonol; 2000 Oct; 30(4):282-90. PubMed ID: 11015127 [TBL] [Abstract][Full Text] [Related]
2. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia. Bassler D Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104 [TBL] [Abstract][Full Text] [Related]
3. Predictive value of measurements of respiratory mechanics in preterm infants with HMD. Freezer NJ; Sly PD Pediatr Pulmonol; 1993 Aug; 16(2):116-23. PubMed ID: 8367217 [TBL] [Abstract][Full Text] [Related]
4. Lung function abnormalities in infants developing bronchopulmonary dysplasia. May C; Kennedy C; Milner AD; Rafferty GF; Peacock JL; Greenough A Arch Dis Child; 2011 Nov; 96(11):1014-9. PubMed ID: 21908881 [TBL] [Abstract][Full Text] [Related]
5. Relative likelihood of bronchopulmonary dysplasia based on pulmonary mechanics measured in preterm neonates during the first week of life. Bhutani VK; Abbasi S J Pediatr; 1992 Apr; 120(4 Pt 1):605-13. PubMed ID: 1552402 [TBL] [Abstract][Full Text] [Related]
7. Early prediction of moderate to severe bronchopulmonary dysplasia in extremely premature infants. Sharma A; Xin Y; Chen X; Sood BG Pediatr Neonatol; 2020 Jun; 61(3):290-299. PubMed ID: 32217025 [TBL] [Abstract][Full Text] [Related]
8. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K; Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158 [TBL] [Abstract][Full Text] [Related]
9. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis. Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675 [TBL] [Abstract][Full Text] [Related]
10. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619 [TBL] [Abstract][Full Text] [Related]
11. Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia. Yeh TF; Chen CM; Wu SY; Husan Z; Li TC; Hsieh WS; Tsai CH; Lin HC Am J Respir Crit Care Med; 2016 Jan; 193(1):86-95. PubMed ID: 26351971 [TBL] [Abstract][Full Text] [Related]
12. Birth weight and early lung compliance as predictors of short-term outcome in premature infants with respiratory distress syndrome. Smith J; van Lierde S; Devlieger H; Daniels H; Eggermont E S Afr Med J; 1995 Nov; 85(11):1157-60. PubMed ID: 8597004 [TBL] [Abstract][Full Text] [Related]
13. Chronic lung disease in extremely low birth weight infants: a two-year retrospective analysis. Su BH; Hu PH; Peng CT; Tsai CH Acta Paediatr Taiwan; 2000; 41(2):75-9. PubMed ID: 10927943 [TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia. McEvoy C; Bowling S; Williamson K; McGaw P; Durand M Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874 [TBL] [Abstract][Full Text] [Related]
15. Bubble nasal CPAP, early surfactant treatment, and rapid extubation are associated with decreased incidence of bronchopulmonary dysplasia in very-low-birth-weight newborns: efficacy and safety considerations. Friedman CA; Menchaca RC; Baker MC; Rivas CK; Laberge RN; Rios EH; Haider SH; Romero EJ; Eason EB; Fraley JK; Woldesenbet M Respir Care; 2013 Jul; 58(7):1134-42. PubMed ID: 23106970 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary function until two years of life in infants with bronchopulmonary dysplasia. Baraldi E; Filippone M; Trevisanuto D; Zanardo V; Zacchello F Am J Respir Crit Care Med; 1997 Jan; 155(1):149-55. PubMed ID: 9001304 [TBL] [Abstract][Full Text] [Related]
18. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. Oh W; Poindexter BB; Perritt R; Lemons JA; Bauer CR; Ehrenkranz RA; Stoll BJ; Poole K; Wright LL; J Pediatr; 2005 Dec; 147(6):786-90. PubMed ID: 16356432 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary outcome in extremely low birth weight infants. Fitzgerald DA; Mesiano G; Brosseau L; Davis GM Pediatrics; 2000 Jun; 105(6):1209-15. PubMed ID: 10835059 [TBL] [Abstract][Full Text] [Related]
20. Chronic lung disease of the very low birth weight infant--is it preventable? Ogawa Y Turk J Pediatr; 1998; 40(1):35-44. PubMed ID: 9673527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]